<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966729</url>
  </required_header>
  <id_info>
    <org_study_id>REDEAL-HF</org_study_id>
    <nct_id>NCT03966729</nct_id>
  </id_info>
  <brief_title>Relationships and Differences Analysis in Heart Failure</brief_title>
  <acronym>REDEAL-HF</acronym>
  <official_title>Retrospektive Datenanalyse Von Herzinsuffizienzpatienten in Der Kardiologie Des Universitätsklinikums Würzburg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuerzburg University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study characterizes heart failure patients who attended the University Hospital
      Würzburg. The primary aim is a better understanding of the relationships and differences
      between the subgroups HFrEF (EF &lt; 40%), HFmrEF (EF 40-49%), and HFpEF (EF&gt;50%), contributing
      to an improved diagnosis, prognosis and therapy of patients with heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The varying clinical picture of heart failure (HF) represents a major challenge for patient
      care in Germany. HF is one of the most common reasons for hospitalization in the Western
      world. In the chronic course of heart failure, affected patients are committed to morbidity,
      lifelong therapy and high risk of cardiac decompensation, also associated with high
      mortality.

      Heart failure patients, who visited the Cardiology Department of the University Hospital
      Wuerzburg, shall be analyzed with regard to all clinical data and outcome. This retrospective
      work should help to better understand the three groups HFrEF (EF &lt; 40%), HFmrEF (EF 40-49%)
      and HFpEF (EF&gt;50%) and help identifying similarities and differences between the groups.

      Hereby we hope for progress in diagnostic, prognostic and therapeutic aspects of heart
      failure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term survival in heart failure patients with preserved, mid-range or reduced left ventricular ejection fraction</measure>
    <time_frame>1 year follow up after last examination</time_frame>
    <description>Survival of patients with heart failure extracted from medical record or by telephone interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of clinical imaging and laboratory parameters on long-term survival in heart failure patients with precerved, mid-range or reduced left ventricular ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>Parameters are derived from standard echocardiography, cardiac magnetic resonance imaging and blood testing.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Heart Failure</condition>
  <condition>Chronic Heart Failure</condition>
  <condition>Chronic Heart Disease</condition>
  <arm_group>
    <arm_group_label>HFrEF</arm_group_label>
    <description>HFrEF (Heart failure with reduced ejection fraction): ESC Guideline heart failure 2016: patients with LVEF &lt; 40%.
LVEF = Left ventricular ejection fraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFmrEF</arm_group_label>
    <description>HFmrEF (Heart failure with mid-range reduced ejection fraction): ESC Guideline heart failure 2016: patients with LVEF 40-49%.
LVEF = Left ventricular ejection fraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFpEF</arm_group_label>
    <description>HFmrEF (Heart failure with preserved ejection fraction): ESC Guideline heart failure 2016: patients with LVEF &gt; 50%.
LVEF = Left ventricular ejection fraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Time (outcome)</intervention_name>
    <arm_group_label>HFmrEF</arm_group_label>
    <arm_group_label>HFpEF</arm_group_label>
    <arm_group_label>HFrEF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Our cohort consists of patients who attended the Cardiology Department of University
        Hospital Wuerzburg in the time period between 2009 and 2019.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis: Heart failure

          -  Minimum of two echocardiographic examinations in a minimum time frame of six months

          -  Patients must have reached the age of 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Nordbeck, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Nordbeck, MD, PhD</last_name>
    <phone>+49 931 201 39181</phone>
    <email>nordbeck_p@ukw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kai Hu, MD</last_name>
    <phone>+49 931 201 0</phone>
    <email>hu_k@ukw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>May 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>May 28, 2019</last_update_submitted>
  <last_update_submitted_qc>May 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuerzburg University Hospital</investigator_affiliation>
    <investigator_full_name>PD Dr. Peter Nordbeck</investigator_full_name>
    <investigator_title>Head Consultant Cardiology</investigator_title>
  </responsible_party>
  <keyword>HFmrEF</keyword>
  <keyword>HFrEF</keyword>
  <keyword>HFpEF</keyword>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

